Mucosal immunisation of mice with malaria protein on lactic acid bacterial cell walls.
Mice were orally and nasally immunised with a malaria parasite protein, MSA2, expressed in Lactococcus lactis, covalently attached to the peptidoglycan (MSA2cP), or non-covalently rebound to L. lactis cell walls, live Lactobacillus reuteri and Lb. salivarius (MSA2cA). Although there was marked variation within mice of the same inbred strain, the data suggest that the characteristics of serum IgG antibodies formed against MSA2 are influenced by the mouse strain and mode of MSA2 presentation. MSA2-specific IgA antibodies in sera and faecal pellets, and IFNgamma-secreting spleen cells were detectable in some immunised animals. MSA2cA on lactobacilli, although not effective in eliciting serum IgG antibodies, showed a potential for eliciting IgA antibodies in the gut. The presence of MSA2 in L. lactis tended to divert the antibody response from lactococcal antigens. The data suggest that anti-MSA2 and anti-lactococcal antibody responses are not necessarily associated in the mice. The findings are related to the use of lactic acid bacteria expressing heterologous proteins for therapy and vaccination.
Moorthy
G
G
National Science Foundation, Maitland Place, Colombo, Sri Lanka; Institute of Fundamental Studies, Kandy, Sri Lanka.
Ramasamy
R
R
D000818:Animals; D000907:Antibodies, Bacterial / Q000097:blood; D000913:Antibodies, Protozoan / Q000097:blood; D000953:Antigens, Protozoan / Q000737:chemistry / Q000235:genetics / Q000276:immunology*; D002473:Cell Wall / Q000737:chemistry*; D005243:Feces / Q000737:chemistry; D005260:Female; D007114:Immunization / Q000379:methods*; D007070:Immunoglobulin A / Q000032:analysis / Q000097:blood; D007371:Interferon-gamma / Q000096:biosynthesis; D007778:Lactobacillus / Q000737:chemistry / Q000276:immunology*; D052200:Limosilactobacillus reuteri / Q000737:chemistry / Q000276:immunology*; D013294:Lactococcus lactis / Q000235:genetics / Q000276:immunology*; D008288:Malaria / Q000517:prevention & control; D017780:Malaria Vaccines / Q000008:administration & dosage / Q000276:immunology; D008297:Male; D051379:Mice; D008809:Mice, Inbred C3H; D008810:Mice, Inbred C57BL; D009092:Mucous Membrane / Q000276:immunology*; D015800:Protozoan Proteins / Q000737:chemistry / Q000235:genetics / Q000276:immunology*; D013045:Species Specificity
D000907:Antibodies, Bacterial; D000913:Antibodies, Protozoan; D000953:Antigens, Protozoan; D007070:Immunoglobulin A; D017780:Malaria Vaccines; D015800:Protozoan Proteins; C065974:merozoite surface protein 2, Plasmodium; D007371:Interferon-gamma